Cutting edge technologies in chronic inflammation research

Jon D. Laman*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

1 Citation (Scopus)
74 Downloads (Pure)

Abstract

This concise review provides the broad background and selection from the literature for a Keynote lecture at EHSF 2022 on state of the art technologies in inflammation research, with an emphasis on disease of the skin and the nervous system. The value of ex vivo skin explant models is discussed, as well as the innovative use of animal models, wherein the crucial roles of antigen experience and "wild" microbiota are emphasized. Spectral flow cytometry allowing large surface marker panels to be explored is touched upon, as well as multiplex technology for cytokines and other analytes important for inflammation and tissue damage. Single-cell sequencing and in situ transcriptomics (spatial profiling) now provide exciting granular information on functional cell subsets, interactions and plasticity. A selection of novel research and diagnostic tools for antibodies against linear peptides or gangliosides is presented. Finally, the review discusses a new anti-inflammatory strategy against skin inflammation with a panel of protease inhibitors derived from the protein fraction of industrial starch potatoes.

Original languageEnglish
Pages (from-to)17-21
Number of pages5
JournalExperimental dermatology
Volume31
Issue numberS1
Early online date4-Sept-2022
DOIs
Publication statusPublished - 2022

Keywords

  • animal model
  • diagnostic tools
  • ex vivo model
  • gut microbiota
  • inflammation
  • nervous system
  • protease inhibitors
  • single-cell sequencing
  • skin
  • spatial profiling
  • spectral flow cytometry
  • SKIN INFLAMMATION
  • AUTOIMMUNE ENCEPHALOMYELITIS
  • PROTEASE INHIBITORS
  • PEPTIDE
  • MICE
  • INDUCTION
  • SYSTEM
  • MYELIN

Fingerprint

Dive into the research topics of 'Cutting edge technologies in chronic inflammation research'. Together they form a unique fingerprint.

Cite this